The nasal spray reverses opioid overdoses and public health officials hope that making it more widely available could save lives and reduce the nation’s high rates of drug fatalities.
Category: Drugs (Pharmaceuticals)
-
F.D.A. Approves Narcan for Over-the-Counter Sales
The New York Times – Business: -
Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles
The New York Times – Business:The Food and Drug Administration is expected this week to allow the overdose-reversal medication to be sold without a prescription, a step toward making it a common emergency tool.
-
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The New York Times – Business:The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
-
Rising Rate of Drug Shortages Is Framed as a National Security Threat
The New York Times – Business:A Senate homeland security committee examined growing health care shortages amid reports of rationing within hospitals.
-
Sanofi Plans to Cut the Price of Insulin
The New York Times – Business:The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
-
F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment
The New York Times – Business:While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.
-
What to Know About the Recent Eye Drop Recalls
The New York Times – Business:Global Pharma recalled eye drops in February after they were tied to a drug-resistant bacteria strain linked to at least one death. Two more companies have since recalled eye drops.
-
Texas Judge Hears Case to End Federal Approval of Abortion Pill
The New York Times – Business:The judge said he would decide soon whether to issue a preliminary injunction ordering the F.D.A. to withdraw its approval of the drug or wait for the full trial.
-
Novo Nordisk Says It Will Slash the Price of Insulin
The New York Times – Business:The company’s decision follows a similar move by its rival, Eli Lilly, this month.
-
How an Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugs
The New York Times – Business:An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.
-
F.D.A. Approves New Nasal Spray for Migraines
The New York Times – Business:Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.
-
Preterm Birth Drug Withdrawn After 12 Years
The New York Times – Business:The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.